|
Volumn 336, Issue 1, 1997, Pages 65-67
|
Thrombolytic therapy in acute ischemic stroke [1] (multiple letters)
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
HEPARIN;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
BRAIN HEMORRHAGE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DISABILITY;
DRUG EFFICACY;
DRUG SAFETY;
FIBRINOLYTIC THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
TREATMENT OUTCOME;
ACUTE DISEASE;
CEREBROVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
NOTE;
BRAIN ISCHEMIA;
METHODOLOGY;
ACUTE DISEASE;
CEREBRAL HEMORRHAGE;
CEREBROVASCULAR DISORDERS;
HUMANS;
STREPTOKINASE;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
BRAIN ISCHEMIA;
RESEARCH DESIGN;
|
EID: 0031019501
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199701023360112 Document Type: Letter |
Times cited : (7)
|
References (18)
|